Clearance Summary
ANGIOTENSIN I IMMUTOPE KIT received FDA 510(k) clearance under submission number K761267, sponsored by Squibb & Sons, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1976-12-30.
- Submission: K761267
- Applicant / Sponsor: Squibb & Sons, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1085
- Decision date: 1976-12-30
Classification & Regulation
This clearance is catalogued under FDA product code CIB and 21 CFR 862.1085, within the Clinical Chemistry review panel as a Class II device.